EGI
MED icon

EAM Global Investors’s Medifast MED Stock Holding History

EAM Global Investors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,158
Closed -$826K – 176
2018
Q2 		$826K Sell
5,158
-11,158
-68% -$1.43M 0.4% 142
2018
Q1 		$1.52M Sell
16,316
-4,131
-20% -$309K 0.79% 19
2017
Q4 		$1.43M Buy
+20,447
New +$1.36M 0.73% 20

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

EAM Global Investors's MED Position: Q3 2018 in Review

EAM Global Investors sold out of Medifast (MED) in Q3 2018, closing a stake of 5,158 shares — an estimated $826K sold.

EAM Global Investors first reported a position in MED in Q4 2017 and held it in 3 quarters. The position peaked at $1.52M in Q1 2018. 266 funds tracked by Wall St. Rank hold MED as of Q3 2018.

  • EAM Global Investors reported no remaining Medifast position as of Q3 2018 after selling out during the quarter.
  • EAM Global Investors sold 5,158 Medifast shares in Q3 2018, an estimated $826K.
  • EAM Global Investors first reported a position in Medifast in Q4 2017 and held it in 3 quarters.
  • EAM Global Investors's Medifast position peaked at $1.52M in Q1 2018.
  • 266 funds tracked by Wall St. Rank held Medifast as of Q3 2018.

Based on EAM Global Investors's 13F filing for Q3 2018, filed 8 Nov 2018.